EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $299 | -59.5% | 40,700 | -42.9% | 0.00% | -50.0% |
Q1 2023 | $738 | -40.9% | 71,276 | -32.6% | 0.00% | -33.3% |
Q4 2022 | $1,248 | -99.9% | 105,676 | 0.0% | 0.00% | -40.0% |
Q3 2022 | $2,218,000 | -32.4% | 105,676 | 0.0% | 0.01% | -28.6% |
Q2 2022 | $3,280,000 | -24.4% | 105,676 | 0.0% | 0.01% | -12.5% |
Q1 2022 | $4,339,000 | +9.1% | 105,676 | +15.5% | 0.01% | +14.3% |
Q4 2021 | $3,976,000 | +162.1% | 91,476 | +201.9% | 0.01% | +133.3% |
Q3 2021 | $1,517,000 | -20.5% | 30,300 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,908,000 | -32.2% | 30,300 | 0.0% | 0.00% | -40.0% |
Q1 2021 | $2,815,000 | -4.8% | 30,300 | -8.2% | 0.01% | 0.0% |
Q4 2020 | $2,956,000 | +10.5% | 33,000 | +27.4% | 0.01% | 0.0% |
Q3 2020 | $2,676,000 | +30.7% | 25,900 | 0.0% | 0.01% | +25.0% |
Q2 2020 | $2,048,000 | +16.1% | 25,900 | -15.1% | 0.00% | 0.0% |
Q1 2020 | $1,764,000 | +51.4% | 30,500 | +72.3% | 0.00% | +100.0% |
Q3 2018 | $1,165,000 | -67.7% | 17,700 | -75.2% | 0.00% | -66.7% |
Q2 2018 | $3,604,000 | -68.2% | 71,400 | -66.9% | 0.01% | -66.7% |
Q1 2018 | $11,351,000 | -67.3% | 215,600 | -71.1% | 0.02% | -67.3% |
Q4 2017 | $34,690,000 | +30.8% | 746,518 | +13.9% | 0.06% | +25.0% |
Q3 2017 | $26,516,000 | +23.2% | 655,547 | +3.3% | 0.04% | +15.8% |
Q2 2017 | $21,523,000 | +19.0% | 634,715 | +1.9% | 0.04% | +15.2% |
Q1 2017 | $18,083,000 | +1.2% | 622,715 | +14.4% | 0.03% | 0.0% |
Q4 2016 | $17,872,000 | +47.4% | 544,215 | +41.5% | 0.03% | +37.5% |
Q3 2016 | $12,124,000 | +42.8% | 384,535 | +27.3% | 0.02% | +41.2% |
Q2 2016 | $8,493,000 | +10.2% | 302,035 | +42.5% | 0.02% | +6.2% |
Q1 2016 | $7,706,000 | -38.0% | 211,997 | -31.7% | 0.02% | -40.7% |
Q4 2015 | $12,422,000 | +135.1% | 310,497 | +67.4% | 0.03% | +125.0% |
Q3 2015 | $5,284,000 | -10.2% | 185,480 | +3.9% | 0.01% | 0.0% |
Q2 2015 | $5,884,000 | +73.9% | 178,602 | +51.8% | 0.01% | +71.4% |
Q1 2015 | $3,384,000 | -41.7% | 117,666 | -44.8% | 0.01% | -41.7% |
Q4 2014 | $5,802,000 | +5478.8% | 213,075 | +4248.5% | 0.01% | – |
Q3 2014 | $104,000 | -5.5% | 4,900 | 0.0% | 0.00% | – |
Q2 2014 | $110,000 | – | 4,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |